Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness | MicrobiomeTrials← Back to trialsNCT07813507
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2027-01Est. Completion: 2029-01
Enrollment target: 64 participants Locations- Foothills Medical Centre, Calgary, Alberta, Canada
Other microbiome trials you might be interested in
Severe SepsisCarbapenem Resistant Bacterial Infection
This prospective observational study is conducted at the First Affiliated Hospital of Zhejiang University School of Medi…
Hangzhou, ChinaCompleted Sep 8, 2023
Primary Hypomagnesemia (Disorder)
Hypomagnesemia (low magnesium) is an electrolyte imbalance commonly found in up to 65% of critically ill patients. Possi…
Charleston, United StatesCompleted Apr 2012
Recruiting
This clinical trial aims to test the effectiveness and safety of semaglutide, a GLP-1 receptor agonist, in treating mode…
Long Beach, United StatesEst. completion Mar 31, 2029